Botanical species · safety record

Brassica juncea

The EFSA Compendium of Botanicals holds 5 constituent measurements for Brassica juncea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Brassica juncea (L.) Czern.

5Constituent measurements
0Safety records
4Cited sources
21Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 21 licensed products naming Brassica juncea as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Brassica juncea - leaf
  • Leaf
  • Leaf/Leaves
  • Seed extract
  • Seed(s)
  • Sprouted seed
  • Stem(s)
  • Whole plant

What the records describe

Constituents measured

  • Glucosinolates3
  • Allyl isothiocyanate1
  • Sinigrin1

Plant parts

  • Seed2
  • Shoot2
  • Leaves1

Preparations

  • Solvent extraction4
  • Essential oil1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
GlucosinolatesShootSolvent extraction≥ 37 Millimole/kilogramStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
GlucosinolatesLeavesSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
GlucosinolatesShootSolvent extraction≤ 66 Millimole/kilogramStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Allyl isothiocyanateSeedEssential oilGaschromatography (GC)No resolvable identifier
SinigrinSeedSolvent extractionGaschromatography (GC)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Antonious, George F., Bomford, Michael., Vincelli, Paul. Screening Brassica species for glucosinolate content. Journal of environmental science and health part b-pesticides food contaminants and agricultural wastes, 2009, vol. 44, no. 3, p. 311-316. DOI
  2. Nayar, J. K., Thorsteinson, A. J. The chemical basis of insect-host relations in an oligophagous insect, Plutella maculipennis. Canadian journal of zoology, 1963, p. 923-929.
  3. Kumar, Akhilesh., D'Souza, Saritha S., Tickoo, Sanjay., Salimath, Bharathi P., Singh, H. B. Antiangiogenic and proapoptotic activities of allyl isothiocyanate inhibit ascites tumor growth in vivo. Integrative cancer therapies, 2009, p. 75-87.
  4. Almuziny, Makhdora., Decker, Charlotte., Wang, Dong., Gerard, Patrick., Tharayil, Nishanth. Nutrient Supply and Simulated Herbivory Differentially Alter the Metabolite Pools and the Efficacy of the Glucosinolate-Based Defense System in Brassica Species . Journal of chemical ecology, 2017, vol. 43, no. 2, p. 129-142. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue